Naja-comp.
Drughomeopathic remedy
Other names: Naja compositum
NCT Number: NCT01048411
The homeopathic remedy 'naja-comp' will improve functional outcome measured by the Barthel-Index.
The homeopathic remedy 'naja-comp' will decrease complications during geriatric rehabilitation measured by rate of unplanned discharge to hospital.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
KWA Stift Rottal, Bad Griesbach, Bavaria, Germany
Secondary outcome for functional improvement are Scandinavian Stroke Scale, 4D+S-Scale and Timed-Up&Go-Test.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
homeopathic remedy
Other names: Naja compositum
s.c. injection of NaCl-solution three times a week
Other names: NaCl 0.9%
Time frame: baseline, 21st day of rehabilitation
Time frame: until day 21 of rehabilitation
Time frame: baseline, 21st day of rehabilitation
University of Erlangen-Nürnberg Medical School
Other
Multicenter Randomized Controlled Trial to Investigate the Influence of the Homeopathic Remedy 'Naja-comp' on Stroke Therapy in Geriatric Rehabilitation
Acronym: naja-comp
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04947865
Brain Diseases, Cardiovascular Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT05570461
Brain Diseases, Cardiovascular Diseases
Peshawar, KPK, Pakistan
View Trial DetailsNCT05542121
Brain Diseases, Cardiovascular Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06392802
Brain Diseases, Cardiovascular Diseases
Barcelona, Spain
View Trial Details